Elsevier,

Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the data on clinical and epidemiological predictors of antidepressant response, or predictors of treatment-resistant depression and discussing the possible prognostic value of clinical features, like severity, chronicity, subtypes of depression, comorbidities, history of trauma, and epidemiological features like gender, age, sociodemographic status.
Elsevier,

The Neuroscience of Autism, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the history and evolution of the definition and characterization of autism over the past several decades and the impact of it on how the disorder is perceived by autistic individuals, families, and professionals
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting the design, execution, and test results of the dyslexia health management system; and highlighting the high potential for worldwide deployment using blockchain technology.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining Pharmacoepigenetics as an emerging field and the relation of epigenetic mechanisms to treatment response to inform treatment selection.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining race, ethnicity, culture, national origin, color, gender, gender identity, sexual orientation, class, age, marital status, political belief, religion, geographic region, mental or physical disability, and historical or current experiences with the dominant culture to fully understand human behavior.
Elsevier,

iPSCs - State of the Science
Volume 16 in Advances in Stem Cell Biology
2022, Pages 197-224

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by focusing on the uses of iPSCs in inherited diseases and, particularly, in the case of Gaucher disease (GD).
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by highlighting the types of human podiatry disabilities and correction methods using traditional, 3DP technology and its challenges.
Elsevier,

Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders, Second Edition, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by providing a framework for understanding neurodevelopment, explore the detection and diagnosis of developmental disabilities, describe techniques for investigation of the mechanisms of these disorders, and present principles of management.
Supports SDG 3: biological diversity of parasites makes treatment of Chagas Disease difficult
Elsevier,

Progress in Brain Research
Volume 268, Issue 1, 2022, Pages 191-215

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information about pituitary adenomas and the complex collection of disorders they produce.

Pages